Jan-07 -

Gastro-Intestinal Group

EORTC 40004 – CLOCC trial (Chemotherapy + Local ablation versus Chemotherapy). Randomized phase II study investigating the role of local treatment of liver metastases by radiofrequency combined with chemotherapy and of chemotherapy alone in patients with unresectable colorectal liver metastases.

EORTC found that aggressive local treatment (which includes radiofrequency ablation +/ – resection) can prolong overall survival (OS) in patients with unresectable colorectal liver metastases.

READ MORE

Go to Top